Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Persistent and emerging racial gaps in mortality from malignant hematologic malignancies, 2018–2023

View Full Paper
Ask AI
Bookmark
Share

Authors

DGDhruvkumar GadhiyaSt. Luke's University Health Network

Discussion

Loading...

Member takes

Implication

Retrospective study finds mortality declines in some racial groups, highlighting persistent racial disparities in hematologic malignancies.

Key Points

  • Mortality from malignant hematologic malignancies declined marginally, with complex changes across racial groups.
  • In 2023, reported deaths from these malignancies reached 343,883, with differing trends by subtype.
  • Analysis of CDC WONDER data revealed trends in mortality by race and population characteristics from 2018 to 2023.
  • Results suggest persistent and emerging racial disparities in cancer outcomes, necessitating targeted interventions.

Cite This Study

Dhruvkumar Gadhiya (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5dchttps://doi.org/10.1182/blood-2025-8081
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends and disparities in premature mortality from hematologic malignancies: Analysis of CDC wonder data, 1999-20202025
  2. 2Mortality trends in chronic myeloid leukemia in the United States: A population-based analysis2025
  3. 3Temporal trends and demographic disparities in myelodysplastic syndrome-associated mortality in Acute Myeloid Leukemia patients in the United States: A population-based analysis (1999–2023)2025
  4. 4Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)2025
  5. 5Impact of sociodemographic factors on survival outcomes in chronic myeloid leukemia in the United States: A time-trend analysis2025